Clinical trials
Hepatitis C trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 14 |
| 2012 | 12 |
| 2013 | 8 |
| 2014 | 10 |
| 2015 | 11 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 83 |
| Unknown status | 11 |
| Terminated | 6 |
| Recruiting | 5 |
| No longer available | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kirby Institute | 26 |
| Gilead Sciences | 19 |
| Bristol-Myers Squibb | 16 |
| Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 8 |
| AbbVie | 5 |
| Debiopharm International SA | 4 |
| GlaxoSmithKline | 4 |
| Janssen R&D Ireland | 4 |
| Human Genome Sciences Inc. | 3 |
| Bayside Health | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 107 |
| Hepatitis C, Chronic | 26 |
| Hepatitis | 10 |
| Bronchiolitis Obliterans Syndrome | 6 |
| Fibrosis | 4 |
| HIV Infections | 3 |
| Liver Diseases | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Chronic Pain | 1 |
| Communicable Diseases | 1 |
Trials
Showing 51 to 75 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.